Galecto IPF Phase IIb trial goes full steam ahead

shutterstock_539844238
Galecto has recruited more than 150 patients to date for its Phase IIb GALACTIC-1 study of GB0139 for idiopathic pulmonary fibrosis (IPF). Credit: zlikovec / Shutterstock.